Document is current

Any future updates will be listed below

Correction: Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)

Crossref DOI link: https://doi.org/10.1186/s12885-024-12592-0

Published Online: 2024-07-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark